Das 1805 gegründete Universitätsklinikum Tübingen ist das Klinikum der Universität Tübingen. Gemeinsam mit der medizinischen Fakultät der Universität. Die Einrichtungen des Universitätsklinikums Tübingen sind überwiegend auf zwei Klinikareale verteilt.

During the past decade, University Hospital of Tuebingen conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Tuebingen" #1 sponsor was "University Hospital Tuebingen" with 21 trials, followed by "Philogen S.p.A." with 3 trials sponsored, "Arrowhead Pharmaceuticals" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "CSL Behring" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Tuebingen" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Eudax S.r.l." with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Herzzentrum Bad Krotzingen" with 1 trials as a collaborator and "Humboldt-Universität zu Berlin" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Tuebingen" are "Covid19" (2 trials), "Hepatitis B" (2 trials), "Adenocarcinomas of the Pancreas" (1 trials), "Anastomotic Leak Esophagus" (1 trials) and "Anemia of Prematurity" (1 trials). Many other conditions were trialed in "University Hospital of Tuebingen" in a lesser frequency.

Most popular intervention types in "University Hospital of Tuebingen" are "Drug" (16 trials), "Other" (8 trials), "Procedure" (6 trials), "Biological" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (2 trials), "Gemcitabine" (2 trials), "antihistamine" (2 trials) and "entecavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Tuebingen" are 34 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital of Tuebingen". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University Hospital of Tuebingen, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Tuebingen, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".